1. 1. ICH Q3A (R2) Impurities in New Drug Substances: Step 5. Note for Guidance on Impurities Testing: Impurities in New Drug Substances (CPMP/ICH/2737/99), EMEA (2006).
2. 2. ICH Topic Q1B: Photostability Testing of New Active Substances and Medicinal Products: Step 5. Note for Guidance on the Photostability Testing of New Active Substances and Medicinal Products (CPMP/ICH/279/95), EMEA (2006).
3. 3. M.V.Murlykina, Y.I.Sakhno, S.M.Desenko et al., Eur. J. Org. Chem., 20, 4481 (2015).
4. 4. M.Rashid, A.Husain, R.Mishra, Eur. J. Medic. Chem., 54, 855 (2012).
5. 5. P.Pace, S.A.H.Spieser, V.Summa, Bioorg. Medic. Chem. Lett., 18, 3865 (2008).